Invivyd IVVD
NASDAQ IVVD
$0.60 +0.03 (+5.26%)
At close: Nov 11, 2026 · 4:00 PM EST

Invivyd (IVVD) EPS (Diluted) (2021 - 2026)

Updated

Invivyd (IVVD) recorded EPS (Diluted) of -$0.14 in Q2 2026, compared with -$0.12 a year earlier.

Analysis

Invivyd (IVVD) EPS (Diluted) (2021 - 2026) Analysis & Trends

On a TTM basis, Invivyd's EPS (Diluted) came in at -$0.25 as of Jun 30, 2026; for FY2025, it was -$0.30.

  • Across earlier years, EPS (Diluted) came in at -$1.43 in FY2024, -$1.81 in FY2023, -$2.23 in FY2022 and -$5.32 in FY2021.
  • The Q2 2026 figure is the lowest quarterly EPS (Diluted) since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.22
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.09
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.38
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.04
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.00
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 7.08
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.94
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.56
10 Invivyd 168.01 Mn -487.88 Mn 13.01 Mn -0.14
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.14
Mar 31, 2026 -0.13
Dec 31, 2025 -0.06
Sep 30, 2025 -0.06
Jun 30, 2025 -0.12
Mar 31, 2025 -0.14
Dec 31, 2024 -0.16
Sep 30, 2024 -0.51
Jun 30, 2024 -0.40
Mar 31, 2024 -0.38
Dec 31, 2023 -0.67
Sep 30, 2023 -0.36
Jun 30, 2023 -0.46
Mar 31, 2023 -0.32
Dec 31, 2022 -0.41
Sep 30, 2022 -0.42
Jun 30, 2022 -0.47
Mar 31, 2022 -0.93
Dec 31, 2021 -1.95
Sep 30, 2021 -0.98
API Access

Invivyd EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=IVVD&period=max&api_key=YOUR_API_KEY